GlassScriptPhysician profile
Riple J Hansalia
NPI 1669511721
$31,241.35
in general payments reported to CMS, 2019-2025
45 companies · $2,231 in 2025
The $2,231 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,423 · 2020: $6,053 · 2021: $5,392 · 2022: $4,750 · 2023: $4,664 · 2024: $1,727 · 2025: $2,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,623 · Consulting Fee: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,622.69 |
| Consulting Fee | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,895.14 | 2019-2025 | Watchman Flx, General - Brady, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $1,461.70 | 2019-2025 | Leqvio |
| Abbott Laboratories | $1,122.18 | 2019-2025 | Esprit, Aveir, Gallant |
| Medtronic, INC. | $1,056.07 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Pulseselect, Linq II |
| Janssen Pharmaceuticals, INC | $834.44 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $700.01 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $559.07 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $505.42 | 2021-2025 | Verquvo |
| Atricure, INC. | $414.81 | 2023-2025 | Atriclip Laa Exclusion System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.38 | 2020-2024 | Jardiance |
| Biosense Webster, INC. | $372.71 | 2019-2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $334.93 | 2020-2024 | Farxiga |
| Pfizer INC. | $328.02 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $295.49 | 2019-2024 | |
| Medtronic Vascular, INC. | $256.27 | 2019-2020 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $212.09 | 2021-2025 | Wegovy, Ozempic |
| Bridgebio Pharma, INC. | $205.02 | 2025 | Attruby |
| Cvrx, INC. | $158.33 | 2023-2024 | Barostim Neo System |
| Catheter Precision INC. | $141.72 | 2023 | |
| Amarin Pharma, INC. | $125.54 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.82 | 2019-2025 | Lifevest |
| Philips North America LLC | $94.97 | 2025 | Lm Accessories |
| Esperion Therapeutics, INC. | $90.99 | 2021-2023 | Nexletol |
| Cardiva Medical, INC. | $70.83 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Impulse Dynamics (USA) INC. | $58.66 | 2022-2025 | Optimizer, Optimizer |
| W. L. Gore & Associates, INC. | $54.73 | 2022 | |
| Irhythm Technologies, INC. | $44.79 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $42.18 | 2019-2022 | |
| Edwards Lifesciences Corporation | $40.51 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Kestra Medical Technology Services, INC. | $29.12 | 2024 | Assure Wcd |
| Akcea Therapeutics, INC. | $28.13 | 2020 | |
| Bardy Diagnostics, INC. | $26.50 | 2019 | |
| Altathera Pharmaceuticals LLC | $19.01 | 2025 | Sotalol Hydrochloride |
| Alnylam Pharmaceuticals INC. | $18.08 | 2025 | Onpattro |
| Potrero Medical, INC. | $17.12 | 2023 | |
| Biotronik INC. | $16.74 | 2022 | |
| Daiichi Sankyo INC. | $15.96 | 2023 | Injectafer |
| Kiniksa Pharmaceuticals International, Plc | $14.54 | 2024 | Arcalyst |
| Astellas Pharma US INC | $14.48 | 2021 | |
| Angiodynamics, INC. | $14.23 | 2021 | |
| Tactile Systems Technology INC | $14.20 | 2020 | |
| Gilead Sciences, INC. | $13.93 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $11.84 | 2021 | |
| Acarix USA INC. | $10.54 | 2023 | Cadscor System |
| Infobionic, INC | $7.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riple Hansalia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.